Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wouter Scheper

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Cancer Discovery|May 13, 2026
Mismatch Repair-Proficient Colorectal Cancer can evade Immune Surveillance Through an Intrinsic Suppressive ProgramChiara Maria Cattaneo, Sharon Scardellato, Gianluca Mauri, et al.
Cell Reports|May 24, 2016
RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell ReceptorZsolt Sebestyen, Wouter Scheper, Anna Vyborova, et al.
Nature Biotechnology|April 23, 2024
Discovery of tumor-reactive T cell receptors by massively parallel library synthesis and screeningZiva Moravec, Yue Zhao, Rhianne Voogd, et al.
Molecular Therapy. Methods & Clinical Development|September 13, 2021
Characterization and modulation of anti-αβTCR antibodies and their respective binding sites at the βTCR chain to enrich engineered T cellsGuido J J Kierkels, Eline van Diest, Patricia Hernández-López, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
A functionally validated TCR-pMHC database for TCR specificity model developmentMarius Messemaker, Bjørn P Y Kwee, Živa Moravec, et al.
Nature Medicine|December 5, 2018
Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancersWouter Scheper, Sander Kelderman, Lorenzo F Fanchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2025
Biomarker Analysis and Treatment Dynamics Following Preoperative Ipilimumab plus Nivolumab in Locally Advanced Urothelial Cancer from the Phase IB NABUCCO StudyChantal F Stockem, Alberto Gil-Jimenez, Hamza Ali, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Cancer Discovery|May 13, 2026
Mismatch Repair-Proficient Colorectal Cancer can evade Immune Surveillance Through an Intrinsic Suppressive ProgramChiara Maria Cattaneo, Sharon Scardellato, Gianluca Mauri, et al.
Cell Reports|May 24, 2016
RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell ReceptorZsolt Sebestyen, Wouter Scheper, Anna Vyborova, et al.
Nature Biotechnology|April 23, 2024
Discovery of tumor-reactive T cell receptors by massively parallel library synthesis and screeningZiva Moravec, Yue Zhao, Rhianne Voogd, et al.
Molecular Therapy. Methods & Clinical Development|September 13, 2021
Characterization and modulation of anti-αβTCR antibodies and their respective binding sites at the βTCR chain to enrich engineered T cellsGuido J J Kierkels, Eline van Diest, Patricia Hernández-López, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
A functionally validated TCR-pMHC database for TCR specificity model developmentMarius Messemaker, Bjørn P Y Kwee, Živa Moravec, et al.
Nature Medicine|December 5, 2018
Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancersWouter Scheper, Sander Kelderman, Lorenzo F Fanchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2025
Biomarker Analysis and Treatment Dynamics Following Preoperative Ipilimumab plus Nivolumab in Locally Advanced Urothelial Cancer from the Phase IB NABUCCO StudyChantal F Stockem, Alberto Gil-Jimenez, Hamza Ali, et al.
Pageof 2